REVENUE (Tables)

6 Months Ended

Apr. 30, 2026

Revenue from Contract with Customer [Abstract]

The following table presents the company’s total revenue and segment revenue disaggregated by geographical region:



	Three Months Ended April 30,
	2026								2025
	Life Sciences and Diagnostics Markets		Agilent CrossLab		Applied Markets		Total		Life Sciences and Diagnostics Markets		Agilent CrossLab		Applied Markets		Total
	(in millions)
Revenue by Region
Americas	$	363	$	289	$	112	$	764	$	325	$	270	$	83	$	678
Europe	214		222		82		518		177		194		71		442
Asia Pacific	155		248		150		553		152		249		147		548
Total	$	732	$	759	$	344	$	1,835	$	654	$	713	$	301	$	1,668



	Six Months Ended April 30,
	2026								2025
	Life Sciences and Diagnostics Markets		Agilent CrossLab		Applied Markets		Total		Life Sciences and Diagnostics Markets		Agilent CrossLab		Applied Markets		Total
	(in millions)
Revenue by Region
Americas	$	670	$	562	$	210	$	1,442	$	637	$	531	$	179	$	1,347
Europe	417		437		182		1,036		367		382		156		905
Asia Pacific	324		518		313		1,155		297		496		304		1,097
Total	$	1,411	$	1,517	$	705	$	3,633	$	1,301	$	1,409	$	639	$	3,349

The following table presents the company’s total revenue disaggregated by end markets and by revenue type:


	Three Months Ended				Six Months Ended
	April 30,				April 30,
	2026		2025		2026		2025
	(in millions)
Revenue by End Markets
Pharmaceutical and Biotechnology	$	663	$	603	$	1,303	$	1,188
Diagnostics and Clinical	295		255		558		495
Academia and Government	132		135		262		272
Chemicals and Advanced Materials	412		369		834		748
Food	147		147		313		315
Environmental and Forensics	186		159		363		331
Total	$	1,835	$	1,668	$	3,633	$	3,349

Revenue by Type
Instrumentation	$	618	$	550	$	1,276	$	1,175
Non-instrumentation and other	1,217		1,118		2,357		2,174
Total	$	1,835	$	1,668	$	3,633	$	3,349

Contract Liabilities and Changes in Balances

The following table provides information about contract liabilities (deferred revenue) and the changes in the balances during the six months ended April 30, 2026:


	Contract Liabilities
	(in millions)

Ending balance as of October 31, 2025	$	803
Net revenue deferred in the period	431
Revenue recognized that was included in the contract liability balance at the beginning of the period	(386)
Change in deferrals from customer cash advances, net of revenue recognized	(1)

Currency translation and other adjustments	8
Ending balance as of April 30, 2026	$	855